Patents by Inventor Teresa S. Wiley

Teresa S. Wiley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7879830
    Abstract: Hormone compositions including bioidentical hormones dispersed in a lipid-based cream are provided in syringes for dispensation and self-administration by a user. The compositions, which are topically applied by the user, are percutaneously delivered to the vascular system of the user in accordance with a dosage protocol that causes a rhythmic and cyclic variation in the serum hormone levels that mimics the temporal variation in hormone levels present in the serum of a normal premenopausal woman.
    Type: Grant
    Filed: August 25, 2005
    Date of Patent: February 1, 2011
    Inventor: Teresa S. Wiley
  • Patent number: 6444220
    Abstract: Compositions containing insulin formulated for topical application and a method for using the compositions for the cosmetic treatment of wrinkles. The formulation is useful for contouring the skin for the reduction of wrinkles, furrows and the like. Insulin, delivered transdermally by means of topical application to a portion of skin having wrinkles and/or furrows therein, permeates the epidermis and accumulates in the dermis and subcutaneous tissue underlying the portion of skin. The elevated insulin concentration in the dermis and subcutaneous tissue, relative to the concentration of insulin in other analogous, remotely located tissue, typically in the range of about 25-50 &mgr;U/gm, stimulates the formation of a layer of adipose tissue in the insulin-rich tissue underlying the portion of skin.
    Type: Grant
    Filed: July 20, 2001
    Date of Patent: September 3, 2002
    Inventor: Teresa S. Wiley
  • Publication number: 20010055602
    Abstract: Compositions containing insulin formulated for topical application and a method for using the compositions for the cosmetic treatment of wrinkles. The formulation is useful for contouring the skin for the reduction of wrinkles, furrows and the like. Insulin, delivered transdermally by means of topical application to a portion of skin having wrinkles and/or furrows therein, permeates the epidermis and accumulates in the dermis and subcutaneous tissue underlying the portion of skin. The elevated insulin concentration in the dermis and subcutaneous tissue, relative to the concentration of insulin in other analogous, remotely located tissue, typically in the range of about 25-50&mgr;U/gm, stimulates the formation of a layer of adipose tissue in the insulin-rich tissue underlying the portion of skin.
    Type: Application
    Filed: July 20, 2001
    Publication date: December 27, 2001
    Inventor: Teresa S. Wiley